Opening Recap Market Pulse: Biotech and robotics chatter ripped through markets as institutional...
Archive - September 14, 2025
KALA’s Price Target Just Hit $33—Don’t Miss Out!
Kala Bio (NASDAQ: KALA) is a clinical-stage biopharmaceutical company focused on rare and severe...